Mode
Text Size
Log in / Sign up
N/A N=59 Randomized Single-blind Prevention

SQ53 Disinfectant Wipes for Prevention of CRBSI

Catheter-related Bloodstream Infection

Enrolled (actual)
59
Serious AEs
0.0%
Results posted
Jun 2023
Primary outcome: Primary: Number of Catheter-Related Blood Stream Infections (CRBSI) at 6 Months — 1.98; 2.09; 1.73; 1.02 Infections per 1000 days with catheter

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
SQ53 Wipe (Device); Ethanol Wipe (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
The Cleveland Clinic
Primary completion
Dec 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Catheter-Related Blood Stream Infections (CRBSI) at 6 Months
1.98; 2.09; 1.73; 1.02
SECONDARY
Catheter Exchange Rates
1.41; 1.61; 1.26; 0.68

Summary

SQ53 is a novel antimicrobial, sporicidal solution that is based on a platform of quaternary ammonium chloride compounds. It has been tested against a wide range of bacteria, viruses, spores and fungal pathogens. Extensive laboratory testing has demonstrated the effectiveness of SQ53 impregnated wipes in cleaning surfaces including catheters over a 24 hour plus time period. SQ53 also received an in vitro evaluation of the irritancy potential using a tissue engineered human skin model and was found to have no potential for skin irritation. SQ53 is available as a sterilized pack with a single wipe inside. The pack is easy to open by tearing off the top end and presenting the contents to the operator to remove under sterile conditions. The current study will be a randomized single-blinded placebo-controlled clinical trial for SQ53 wipes intended for catheter cleaning in patients receiving home parenteral nutrition.

Eligibility Criteria

Inclusion Criteria

  • Patients requiring home parenteral nutrition support via PICC line or tunneled CVC.

Exclusion Criteria

  • Age less than 18 years
  • Women known to be pregnant
  • Women of childbearing age who are planning a pregnancy
  • Women who are breastfeeding
  • Patients who will not be managed by Cleveland Clinic HPN service
  • Patients who refuse to use disinfectant wipes daily.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04822467). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search